ObjectivesTo determine whether NALP3 deletion has the ability to ameliorate hyperoxia‐induced acute lung injury.MethodsC57BL/6 mice and age‐matched NALP3 KO mice of the same genetic background were exposed to 100% oxygen. 24–72 hours after exposure to hyperoxia, mice were sacrificed to collect bronchoalveolar lavage fluid (BAL fluid) for cell counts, cytokine measurement with ELISA, and TUNEL staining on BAL fluid cells. Additionally, after 48–72 hour exposure, lung tissues were collected for H&E and TUNEL staining on lung tisue sections, and also for Western blot analysis of Ceaved Caspase‐3 expresssion in lung tissue.ResultsCell count in BAL fluid showed that infiltration of macrophages and neutrophils into lung parenchyma was significantly suppressed in KO mice. The pro‐inflammatory cytokine IL‐1β, TNF‐α, MCP‐1 and MIP‐2 levels in BAL fluid are all significantly suppresed in KO mice. Semi‐quantitative histological evaluation of H&E‐stained lung tissue sections revealed that lung pathological severity score was notably less in KO mice. TUNEL staining on lung tissue sections showed that lung epithelial cell apoptosis in NALP3 KO mice was markedly suppressed when compared to WT mice.ConclusionsThe deletion of NALP3 gene protects against hyperoxia‐induced acute lung injury. This result suggest that inflammasome platform can be a novel target for the treatment of acute lung injury.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.